2′,3′-Dideoxythymidine permeation of the human erythrocyte membrane by nonfacilitated diffusion
- 1 August 1988
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 154 (3), 825-831
- https://doi.org/10.1016/0006-291x(88)90214-8
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Initial studies on the cellular pharmacology of 2′,3′-dideoxyinosine, an inhibitor of HIV infectivityBiochemical Pharmacology, 1987
- Plasma and cerebrospinal fluid pharmacokinetics of 3′-azido-3′-deoxythymidine: A Novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseasesClinical Pharmacology & Therapeutics, 1987
- RESPONSE OF HUMAN-IMMUNODEFICIENCY-VIRUS-ASSOCIATED NEUROLOGICAL DISEASE TO 3'-AZIDO-3'-DEOXYTHYMIDINEThe Lancet, 1987
- Initial studies on the cellular pharmacology of 2′,3′-dideoxycytidine, an inhibitor of HTLV-III infectivityBiochemical Pharmacology, 1986
- An assay for inhibitors of nucleoside transport based upon the use of 5-[125I]iodo-2′-deoxyuridine as permeantAnalytical Biochemistry, 1986
- ADMINISTRATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE, AN INHIBITOR OF HTLV-III/LAV REPLICATION, TO PATIENTS WITH AIDS OR AIDS-RELATED COMPLEXThe Lancet, 1986
- 2-Chloroadenosine, a permeant for the nucleoside transporterBiochemical Pharmacology, 1985
- Structural modifications at the 2'— and 3'— positions of some pyrimidine nucleosides as determinants of their interaction with the mouse erythrocyte nucleoside transporterBiochemical Pharmacology, 1984
- Transport of nucleoside drugs in animal cellsPharmacology & Therapeutics, 1981